H.R. 8574 · 118th Congress

340B ACCESS Act

Introduced on May 28, 2024 by Larry Bucshon (R-IN-8). 2 cosponsors, all from the sponsor's party. Latest action (Dec 17, 2024): Referred to the Subcommittee on Health.

Stage
Introduced
Introduced
May 28, 2024
Cosponsors
2
0 from the other party
Policy area
Health

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes.

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Larry BucshonR-IN-8Sponsor

Republicans · 2

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. May 28, 2024Introduced in House
  2. May 28, 2024Introduced in House
  3. May 28, 2024 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  4. May 28, 2024 · HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  5. May 31, 2024 · HouseReferred to the Subcommittee on Health.
  6. Dec 17, 2024 · HouseReferred to the Subcommittee on Health.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA10 reports
    $29M reported (all issues)
  2. The Hemophilia Alliance4 reports
    $160K reported (all issues)
  3. ADVOCATES FOR COMMUNITY HEALTH3 reports
    $240K reported (all issues)
  4. AMERICAN HOSPITAL ASSOCIATION3 reports
    $18.1M reported (all issues)Federal contractor: AMERICAN HOSPITAL ASSOCIATION$1.2M in contracts, FY2026AI match · 99%
  5. AMGEN INC.3 reports
    $8.3M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  6. Association of American Medical Colleges3 reports
    $2M reported (all issues)Federal contractor: ASSOCIATION OF AMERICAN MEDICAL COLLEGESAI match · 100%
  7. BIOTECHNOLOGY INNOVATION ORGANIZATION3 reports
    $4.9M reported (all issues)
  8. California Hospital Association3 reports
    $1.1M reported (all issues)
  9. Daiichi Sankyo, Inc.3 reports
    $1.1M reported (all issues)Federal contractor: DAIICHI SANKYO, INC$205.9K in contracts, FY2026AI match · 100%
  10. GSK (fka GLAXOSMITHKLINE INC.)3 reports
    $4M reported (all issues)
  11. JOHNSON & JOHNSON SERVICES, INC.3 reports
    $5M reported (all issues)
  12. Job Creators Network3 reports
    $22.5K reported (all issues)
  13. LUNDBECK LLC3 reports
    $420K reported (all issues)Federal contractor: LUNDBECK LLCAI match · 99%
  14. NATIONAL ASSOCIATION OF CHAIN DRUG STORES, INC.3 reports
    $3.2M reported (all issues)
  15. NATIONWIDE CHILDREN'S HOSPITAL, INC.3 reports
    $125K reported (all issues)
  16. PFIZER INC.3 reports
    $5.1M reported (all issues)Federal contractor: PFIZER INCAI match · 100%
  17. Pharmaceutical Research and Manufacturers of America (PhRMA)3 reports
    $90K reported (all issues)
  18. TAKEDA PHARMACEUTICALS AMERICA, INC.3 reports
    $2.4M reported (all issues)Federal contractor: TAKEDA PHARMACEUTICALS AMERICA, INC.$1.6M in contracts, FY2026AI match · 100%
  19. TRINITY HEALTH3 reports
    $600K reported (all issues)Federal contractor: TRINITY HEALTH$226.3K in contracts, FY2026AI match · 95%
  20. The MetroHealth System3 reports
    $410K reported (all issues)
  21. The New York and Presbyterian Hospital3 reports
    $340K reported (all issues)
  22. The University of Toledo3 reports
    $80K reported (all issues)Federal contractor: UNIVERSITY OF TOLEDOAI match · 100%
  23. BIOMARIN PHARMACEUTICAL INC.2 reports
    $730K reported (all issues)
  24. HEALTHCARE ASSOCIATION OF NYS2 reports
  25. NOVARTIS CORPORATION2 reports
    $1.5M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  26. National Association of Community Health Centers2 reports
    $382K reported (all issues)
  27. The Cigna Group and subsidiaries (Formerly Cigna Corporation2 reports
    $3.9M reported (all issues)
  28. The Leukemia & Lymphoma Society2 reports
    $340K reported (all issues)
  29. The Nemours Foundation - a Florida not-for-profit Corporation2 reports
    $400.9K reported (all issues)
  30. University of California2 reports
    $1M reported (all issues)
  31. University of Utah2 reports
    $110K reported (all issues)Federal contractor: UNIVERSITY OF UTAH$21.3M in contracts, FY2026AI match · 100%
  32. Nemours Children's Health1 report
    $40K reported (all issues)
  33. VIRGINIA COMMONWEALTH UNIVERSITY1 report
    $40K reported (all issues)Federal contractor: VIRGINIA COMMONWEALTH UNIVAI match · 100%

Reports filed in 2024, 2025.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 10, 2026 · loaded Oct 10, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.